DX

DexCom

- NASDAQ:DXCM
Last Updated 2021-09-21

LinkedIn Profile

Access DexCom historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Sector Industry
nasdaq:dxcm 42221 Aug 18th, 2021 12:00AM Dexcom 61K 3974 Open Medical Device Aug 18th, 2021 08:40AM Aug 18th, 2021 08:40AM Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes. Since the company’s inception, Dexcom has focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering the community to take control of diabetes. Dexcom reported full-year 2019 revenue of $1.5B, a growth of 42% versus 2018. Headquartered in San Diego, California, with additional offices in the U.S., Europe, and Asia Pacific, the company employs approximately 5,000 people. Open Continuous Glucose Monitoring, Medical Devices, Diabetes, Decision Support, Data, Mobile Software, Sensors Open 6340 Sequence Drive San Diego CA US 92121 Health Care Health Care Equipment & Services
nasdaq:dxcm 42221 Aug 17th, 2021 12:00AM Dexcom 60K 3974 Open Medical Device Aug 17th, 2021 08:37AM Aug 17th, 2021 08:37AM Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes. Since the company’s inception, Dexcom has focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering the community to take control of diabetes. Dexcom reported full-year 2019 revenue of $1.5B, a growth of 42% versus 2018. Headquartered in San Diego, California, with additional offices in the U.S., Europe, and Asia Pacific, the company employs approximately 5,000 people. Open Continuous Glucose Monitoring, Medical Devices, Diabetes, Decision Support, Data, Mobile Software, Sensors Open 6340 Sequence Drive San Diego CA US 92121 Health Care Health Care Equipment & Services
nasdaq:dxcm 42221 Aug 16th, 2021 12:00AM Dexcom 60K 3974 Open Medical Device Aug 16th, 2021 08:21AM Aug 16th, 2021 08:21AM Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes. Since the company’s inception, Dexcom has focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering the community to take control of diabetes. Dexcom reported full-year 2019 revenue of $1.5B, a growth of 42% versus 2018. Headquartered in San Diego, California, with additional offices in the U.S., Europe, and Asia Pacific, the company employs approximately 5,000 people. Open Continuous Glucose Monitoring, Medical Devices, Diabetes, Decision Support, Data, Mobile Software, Sensors Open 6340 Sequence Drive San Diego CA US 92121 Health Care Health Care Equipment & Services
nasdaq:dxcm 42221 Aug 15th, 2021 12:00AM Dexcom 60K 3973 Open Medical Device Aug 15th, 2021 03:46PM Aug 15th, 2021 03:46PM Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes. Since the company’s inception, Dexcom has focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering the community to take control of diabetes. Dexcom reported full-year 2019 revenue of $1.5B, a growth of 42% versus 2018. Headquartered in San Diego, California, with additional offices in the U.S., Europe, and Asia Pacific, the company employs approximately 5,000 people. Open Continuous Glucose Monitoring, Medical Devices, Diabetes, Decision Support, Data, Mobile Software, Sensors Open 6340 Sequence Drive San Diego CA US 92121 Health Care Health Care Equipment & Services
nasdaq:dxcm 42221 Aug 14th, 2021 12:00AM Dexcom 60K 3975 Open Medical Device Aug 14th, 2021 11:42AM Aug 14th, 2021 11:42AM Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes. Since the company’s inception, Dexcom has focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering the community to take control of diabetes. Dexcom reported full-year 2019 revenue of $1.5B, a growth of 42% versus 2018. Headquartered in San Diego, California, with additional offices in the U.S., Europe, and Asia Pacific, the company employs approximately 5,000 people. Open Continuous Glucose Monitoring, Medical Devices, Diabetes, Decision Support, Data, Mobile Software, Sensors Open 6340 Sequence Drive San Diego CA US 92121 Health Care Health Care Equipment & Services
nasdaq:dxcm 42221 Aug 13th, 2021 12:00AM Dexcom 60K 3974 Open Medical Device Aug 13th, 2021 10:14AM Aug 13th, 2021 10:14AM Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes. Since the company’s inception, Dexcom has focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering the community to take control of diabetes. Dexcom reported full-year 2019 revenue of $1.5B, a growth of 42% versus 2018. Headquartered in San Diego, California, with additional offices in the U.S., Europe, and Asia Pacific, the company employs approximately 5,000 people. Open Continuous Glucose Monitoring, Medical Devices, Diabetes, Decision Support, Data, Mobile Software, Sensors Open 6340 Sequence Drive San Diego CA US 92121 Health Care Health Care Equipment & Services
nasdaq:dxcm 42221 Aug 12th, 2021 12:00AM Dexcom 60K 3973 Open Medical Device Aug 12th, 2021 09:02AM Aug 12th, 2021 09:02AM Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes. Since the company’s inception, Dexcom has focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering the community to take control of diabetes. Dexcom reported full-year 2019 revenue of $1.5B, a growth of 42% versus 2018. Headquartered in San Diego, California, with additional offices in the U.S., Europe, and Asia Pacific, the company employs approximately 5,000 people. Open Continuous Glucose Monitoring, Medical Devices, Diabetes, Decision Support, Data, Mobile Software, Sensors Open 6340 Sequence Drive San Diego CA US 92121 Health Care Health Care Equipment & Services
nasdaq:dxcm 42221 Aug 11th, 2021 12:00AM Dexcom 60K 3968 Open Medical Device Aug 10th, 2021 10:41PM Aug 10th, 2021 10:41PM Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes. Since the company’s inception, Dexcom has focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering the community to take control of diabetes. Dexcom reported full-year 2019 revenue of $1.5B, a growth of 42% versus 2018. Headquartered in San Diego, California, with additional offices in the U.S., Europe, and Asia Pacific, the company employs approximately 5,000 people. Open Continuous Glucose Monitoring, Medical Devices, Diabetes, Decision Support, Data, Mobile Software, Sensors Open 6340 Sequence Drive San Diego CA US 92121 Health Care Health Care Equipment & Services
nasdaq:dxcm 42221 Aug 10th, 2021 12:00AM Dexcom 60K 3968 Open Medical Device Aug 10th, 2021 10:09AM Aug 10th, 2021 10:09AM Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes. Since the company’s inception, Dexcom has focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering the community to take control of diabetes. Dexcom reported full-year 2019 revenue of $1.5B, a growth of 42% versus 2018. Headquartered in San Diego, California, with additional offices in the U.S., Europe, and Asia Pacific, the company employs approximately 5,000 people. Open Continuous Glucose Monitoring, Medical Devices, Diabetes, Decision Support, Data, Mobile Software, Sensors Open 6340 Sequence Drive San Diego CA US 92121 Health Care Health Care Equipment & Services
nasdaq:dxcm 42221 Aug 9th, 2021 12:00AM Dexcom 60K 3968 Open Medical Device Aug 9th, 2021 08:47AM Aug 9th, 2021 08:47AM Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes. Since the company’s inception, Dexcom has focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering the community to take control of diabetes. Dexcom reported full-year 2019 revenue of $1.5B, a growth of 42% versus 2018. Headquartered in San Diego, California, with additional offices in the U.S., Europe, and Asia Pacific, the company employs approximately 5,000 people. Open Continuous Glucose Monitoring, Medical Devices, Diabetes, Decision Support, Data, Mobile Software, Sensors Open 6340 Sequence Drive San Diego CA US 92121 Health Care Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.